A Study Evaluating the Safety and Efficacy of a Second Course of TPX-100 in Subjects Who Previously Received TPX-100 for Patellar Osteoarthritis Involving Both Knees

NCT02837900 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

14

Enrollment

INDUSTRY

Sponsor class

Conditions

Knee Osteoarthritis

Interventions

DRUG: TPX-100 200 mg 4 times weekly for 4 weeks
DRUG: TPX-100 200 mg 4 times weekly for 4 weeks

Sponsor

OrthoTrophix, Inc